Skip to Content
 
John P.  Greer

John P. Greer, M.D.

Professor of Medicine (Hematology/Oncology), Pediatrics
Clinical Director, Hematology and Stem Cell Transplantation

Profile

Dr. Greer is a hematologist/oncologist who specializes in hematological malignancies and stem cell transplantation. His research interests are in the clinicopathologic description of hematologic neoplasms and in the development of therapeutic strategies to treat these disorders.

He has an expertise in T cell lymphomas and has a joint cutaneous lymphoma clinic with Dr. John Zic in dermatology. Dr. Greer's extramural activities include Chief Editor for Wintrobe's Clinical Hematology (12th edition, 2009) and member of the Lymphoma Committee for ECOG.

His research interests are in the clinicopathologic descriptions of hematologic neoplasms and in the development of therapeutic strategies to treat those disorders. Specific entities he has helped recognize include anaplastic large cell lymphoma, T-cell-rich B-cell lymphoma, and natural killer-like T-cell lymphoma/leukemia.

Education
  • Undergraduate School & Degree: Vanderbilt University B.A.
  • Medical School & Degree: Vanderbilt University School of Medicine, 1976
  • Post Graduate Training: Tulane University; Medical College of Virginia; Vanderbilt University Medical Center
  • Board & Certifications: Internal Medicine; Pediatrics
  • ABIM & Subspecialty: Hematology; Medical Oncology
Research Description

My research interests are in the clinicopathologic descriptions of hematologic neoplasms and in the development of therapeutic strategies to treat these disorders. Specific entities we have helped recognize include anaplastic large cell lymphoma, T-cell-rich B-cell lymphoma, and natural killer-like T-cell lymphoma/leukemia. Since the early 1980's, we have evaluated short course, dose intensive therapy (MEGA) for intermediate to high grade lymphomas, the use of high dose cytarabine consolidation in acute nonlymphocytic leukemia, and the role of transplantation in hematologic neoplasms. We actively participate in phase I-III trials through cooperative groups (Eastern Cooperative Oncology Group and Children's Oncology Group) and with the pharmaceutical industry. We have an emphasis in studies evaluating novel agents directed at molecular pathways, immunotherapy, and transplantation.

Publications
  • Carson KR, Horwitz SM, Pinter-Brown LC, Rosen ST, Pro B, Hsi ED, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta MA, Shustov AR, Advani RH, Feldman TA, Lechowicz MJ, Smith SM, Lansigan F, Tulpule A, Craig MD, Greer JP, Kahl BS, Leach JW, Morganstein N, Casulo C, Park SI, Foss FM. A prospective cohort study of patients with peripheral T-cell lymphoma in the United States. Cancer [print-electronic]. 2017 Apr 4/1/2017; 123(7): 1174-83. PMID: 27911989, DOI: 10.1002/cncr.30416, ISSN: 1097-0142.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/27911989.
  • Hsi ED, Horwitz SM, Carson KR, Pinter-Brown LC, Rosen ST, Pro B, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta M, Collie AM, Gruver AM, Grzywacz BJ, Turakhia S, Shustov AR, Advani RH, Feldman T, Lechowicz MJ, Smith SM, Lansigan F, Tulpule A, Craig MD, Greer JP, Kahl BS, Leach JW, Morganstein N, Casulo C, Park SI, Foss FM. Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States. Clin Lymphoma Myeloma Leuk [print-electronic]. 2017 Apr; 17(4): 193-200. PMID: 28209473, PII: S2152-2650(16)30575-4, DOI: 10.1016/j.clml.2016.10.001, ISSN: 2152-2669.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/28209473.
  • Johnpulle RA, Paczesny S, Jung DK, Daguindau E, Jagasia MH, Savani BN, Chinratanalab W, Cornell RF, Goodman S, Greer JP, Kassim AA, Sengsayadeth S, Byrne MT, Engelhardt BG. Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling. Biol. Blood Marrow Transplant [print-electronic]. 2017 Mar; 23(3): 529-32. PMID: 28013014, PMCID: PMC5321545, PII: S1083-8791(16)31186-7, DOI: 10.1016/j.bbmt.2016.12.627, ISSN: 1523-6536.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/28013014.
  • Reddy NM, Greer JP, Morgan DS, Chen H, Park SI, Richards KL. A phase II randomized study of lenalidomide or lenalidomide and rituximab as maintenance therapy following standard chemotherapy for patients with high/high-intermediate risk diffuse large B-cell lymphoma. Leukemia [print-electronic]. 2017 Jan; 31(1): 241-4. PMID: 27654851, PMCID: PMC5214342, PII: leu2016255, DOI: 10.1038/leu.2016.255, ISSN: 1476-5551.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/27654851.
  • Shiuan E, Beckermann KE, Ozgun A, Kelly C, McKean M, McQuade J, Thompson MA, Puzanov I, Greer JP, Rapisuwon S, Postow M, Davies MA, Eroglu Z, Johnson D. Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy. J Immunother Cancer. 2017; 5: 8. PMID: 28239462, PMCID: PMC5319013, PII: 210, DOI: 10.1186/s40425-017-0210-0, ISSN: 2051-1426.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/28239462.
  • Kennedy VE, Savani BN, Greer JP, Kassim AA, Engelhardt BG, Goodman SA, Sengsayadeth S, Chinratanalab W, Jagasia M. Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies. Biol. Blood Marrow Transplant [print-electronic]. 2016 Oct; 22(10): 1801-7. PMID: 27377900, PII: S1083-8791(16)30202-6, DOI: 10.1016/j.bbmt.2016.06.029, ISSN: 1523-6536.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/27377900.
  • Nguyen VT, Pophali PA, Tsai JP, Jagadeesh D, Dean RM, Pohlman B, Morgan DS, Greer JP, Smith MR, Hill BT, Reddy NM. Early stage, bulky Hodgkin lymphoma patients have a favorable outcome when treated with or without consolidative radiotherapy: potential role of PET scan in treatment planning [letter]. Br. J. Haematol [print-electronic]. 2016 Jul 7/13/2016; PMID: 27409578, DOI: 10.1111/bjh.14236, ISSN: 1365-2141.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/27409578.
  • Oluwole OO, Zic JA, Douds JJ, Ann Thompson M, Greer JP. Cutaneous manifestations and management of hematologic neoplasms. Semin. Oncol [print-electronic]. 2016 Jun; 43(3): 370-83. PMID: 27178691, PII: S0093-7754(16)00046-4, DOI: 10.1053/j.seminoncol.2016.02.021, ISSN: 1532-8708.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/27178691.
  • Engelhardt BG, Paczesny S, Jung DK, Daguindau E, Jagasia M, Savani BN, Chinratanalab W, Cornell RF, Goodman S, Greer JP, Kassim AA, Sengsayadeth S, Yoder SM, Rock MT, Crowe JE. Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation [letter]. Haematologica [print-electronic]. 2016 May; 101(5): e204-8. PMID: 26819055, PMCID: PMC5004357, PII: haematol.2015.139501, DOI: 10.3324/haematol.2015.139501, ISSN: 1592-8721.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/26819055.
  • Bachanova V, Marks DI, Zhang MJ, Wang H, de Lima M, Aljurf MD, Arellano M, Artz AS, Bacher U, Cahn JY, Chen YB, Copelan EA, Drobyski WR, Gale RP, Greer JP, Gupta V, Hale GA, Kebriaei P, Lazarus HM, Lewis ID, Lewis VA, Liesveld JL, Litzow MR, Loren AW, Miller AM, Norkin M, Oran B, Pidala J, Rowe JM, Savani BN, Saber W, Vij R, Waller EK, Wiernik PH, Weisdorf DJ. Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease. Leukemia [print-electronic]. 2014 Mar; 28(3): 658-65. PMID: 23989431, PMCID: PMC3951192, PII: leu2013253, DOI: 10.1038/leu.2013.253, ISSN: 1476-5551.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23989431.
  • Mask-Bull L, Likhari SB, Zic JA, Greer JP. Hemagglutination during photopheresis. J. Am. Acad. Dermatol. 2014 Mar; 70(3): e61-2. PMID: 24528919, PII: S0190-9622(13)01154-7, DOI: 10.1016/j.jaad.2013.10.037, ISSN: 1097-6787.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24528919.
  • Sengsayadeth S, Savani BN, Jagasia M, Goodman S, Greer JP, Chen H, Chinratanalab W, Kassim AA, Engelhardt BG. Six-month freedom from treatment failure is an important end point for acute GVHD clinical trials. Bone Marrow Transplant [print-electronic]. 2014 Feb; 49(2): 236-40. PMID: 24096824, PMCID: PMC3946331, PII: bmt2013157, DOI: 10.1038/bmt.2013.157, ISSN: 1476-5365.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24096824.
  • Reddy NM, Oluwole O, Greer JP, Engelhardt BG, Jagasia MH, Savani BN. Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma. Exp. Hematol [print-electronic]. 2014 Jan; 42(1): 39-45. PMID: 24096123, PMCID: PMC5002948, PII: S0301-472X(13)00747-9, DOI: 10.1016/j.exphem.2013.09.012, ISSN: 1873-2399.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24096123.
  • Reddy N, Oluwole O, Greer JP, Goodman S, Engelhardt B, Jagasia MH, Savani BN. Superior long-term outcome of patients with early transformation of non-Hodgkin lymphoma undergoing stem cell transplantation. Clin Lymphoma Myeloma Leuk [print-electronic]. 2012 Dec; 12(6): 406-11. PMID: 22981964, PMCID: PMC4845749, PII: S2152-2650(12)00136-X, DOI: 10.1016/j.clml.2012.07.003, ISSN: 2152-2669.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22981964.
  • Sengsayadeth SM, Jagasia M, Engelhardt BG, Kassim A, Strickland SA, Goodman S, Lucid C, Vnencak-Jones CL, Greer JP, Savani BN. Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers. Bone Marrow Transplant [print-electronic]. 2012 Dec; 47(12): 1535-7. PMID: 22659680, PII: bmt201288, DOI: 10.1038/bmt.2012.88, ISSN: 1476-5365.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22659680.
  • Jacobs R, Tran U, Chen H, Kassim A, Engelhardt BG, Greer JP, Goodman SG, Clifton C, Lucid C, Vaughan LA, Savani BN, Jagasia M. Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria. Bone Marrow Transplant [print-electronic]. 2012 Nov; 47(11): 1470-3. PMID: 22484321, PII: bmt201256, DOI: 10.1038/bmt.2012.56, ISSN: 1476-5365.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22484321.
  • Reddy N, Greer JP, Goodman S, Engelhardt B, Oluwole O, Jagasia MH, Savani BN. Long-term outcome after autologous or allogeneic stem cell transplantation in patients with recurrent follicular lymphoma. Bone Marrow Transplant [print-electronic]. 2012 Oct; 47(10): 1318-20. PMID: 22327132, PMCID: PMC4845748, PII: bmt201210, DOI: 10.1038/bmt.2012.10, ISSN: 1476-5365.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22327132.
  • Huntington SF, Talbott MS, Greer JP, Morgan DS, Reddy N. Toxicities and outcomes among septuagenarians and octogenarians with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy. Leuk. Lymphoma [print-electronic]. 2012 Aug; 53(8): 1461-8. PMID: 22260160, DOI: 10.3109/10428194.2012.658793, ISSN: 1029-2403.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22260160.
  • Jagasia M, Clark WB, Brown-Gentry KD, Crawford DC, Fan KH, Chen H, Kassim A, Greer JP, Engelhardt BG, Savani BN. Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignancies. Biol. Blood Marrow Transplant [print-electronic]. 2012 Jul; 18(7): 1069-75. PMID: 22178694, PII: S1083-8791(11)01080-9, DOI: 10.1016/j.bbmt.2011.12.518, ISSN: 1523-6536.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22178694.
  • Chinratanalab W, Reddy N, Greer JP, Morgan D, Engelhardt B, Kassim A, Brandt SJ, Jagasia M, Goodman S, Savani BN. Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignancies. Exp. Hematol [print-electronic]. 2012 Jun; 40(6): 431-5. PMID: 22269114, PMCID: PMC4067702, PII: S0301-472X(12)00016-1, DOI: 10.1016/j.exphem.2012.01.014, ISSN: 1873-2399.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22269114.
  • Reddy N, Greer JP, Goodman S, Kassim A, Morgan DS, Chinratanalab W, Brandt S, Englehardt B, Oluwole O, Jagasia MH, Savani BN. Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimen. Exp. Hematol [print-electronic]. 2012 May; 40(5): 359-66. PMID: 22269117, PMCID: PMC4845757, PII: S0301-472X(12)00014-8, DOI: 10.1016/j.exphem.2012.01.012, ISSN: 1873-2399.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22269117.
  • Clark WB, Brown-Gentry KD, Crawford DC, Fan KH, Snavely J, Chen H, Savani BN, Kassim A, Greer JP, Schuening FG, Engelhardt BG, Jagasia MH. Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD. Blood [print-electronic]. 2011 Jul 7/28/2011; 118(4): 1140-4. PMID: 21628416, PII: blood-2010-09-310011, DOI: 10.1182/blood-2010-09-310011, ISSN: 1528-0020.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/21628416.
  • Engelhardt BG, Jagasia M, Savani BN, Bratcher NL, Greer JP, Jiang A, Kassim AA, Lu P, Schuening F, Yoder SM, Rock MT, Crowe JE. Regulatory T cell expression of CLA or a(4)ß(7) and skin or gut acute GVHD outcomes. Bone Marrow Transplant [print-electronic]. 2011 Mar; 46(3): 436-42. PMID: 20577222, PMCID: PMC3217583, PII: bmt2010127, DOI: 10.1038/bmt.2010.127, ISSN: 1476-5365.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20577222.
  • Tedeschi SK, Jagasia M, Engelhardt BG, Domm J, Kassim AA, Chinratanalab W, Greenhut SL, Goodman S, Greer JP, Schuening F, Frangoul H, Savani BN. Early lymphocyte reconstitution is associated with improved transplant outcome after cord blood transplantation. Cytotherapy [print-electronic]. 2011 Jan; 13(1): 78-82. PMID: 20586668, DOI: 10.3109/14653249.2010.495114, ISSN: 1477-2566.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20586668.
  • Reddy N, Greer JP. Primary bone lymphoma: a set of unique problems in management. Leuk. Lymphoma. 2010 Jan; 51(1): 1-2. PMID: 20055655, DOI: 10.3109/10428190903470877, ISSN: 1029-2403.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20055655.
  • Greer JP, Mosse CA. Natural killer-cell neoplasms. Curr Hematol Malig Rep. 2009 Oct; 4(4): 245-52. PMID: 20425414, DOI: 10.1007/s11899-009-0032-3, ISSN: 1558-822X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20425414.
  • Jagasia MH, Savani BN, Stricklin G, Engelhardt B, Kassim A, Dixon S, Chen H, Chinratanalab W, Goodman S, Greer JP, Schuening F. Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP). Biol. Blood Marrow Transplant [print-electronic]. 2009 Oct; 15(10): 1288-95. PMID: 19747637, PMCID: PMC3159406, PII: S1083-8791(09)00289-4, DOI: 10.1016/j.bbmt.2009.06.007, ISSN: 1523-6536.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/19747637.
  • Engelhardt BG, Holland DW, Brandt SJ, Chinratanalab W, Goodman SA, Greer JP, Jagasia MH, Kassim AA, Morgan DS, Ruffner KL, Schuening FG, Wolff S, Bitting R, Sulur P, Stein RS. High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes. Leuk. Lymphoma. 2007 Sep; 48(9): 1728-35. PMID: 17786708, PII: 781802102, DOI: 10.1080/10428190701534374, ISSN: 1042-8194.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17786708.
  • Sepmeyer JA, Greer JP, Koyama T, Zic JA. Open-label pilot study of combination therapy with rosiglitazone and bexarotene in the treatment of cutaneous T-cell lymphoma. J. Am. Acad. Dermatol [print-electronic]. 2007 Apr; 56(4): 584-7. PMID: 17184879, PII: S0190-9622(06)02865-9, DOI: 10.1016/j.jaad.2006.10.033, ISSN: 1097-6787.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17184879.
  • Schmidt AN, Robbins JB, Greer JP, Zic JA. Conjugal transformed mycosis fungoides: the unknown role of viral infection and environmental exposures in the development of cutaneous T-cell lymphoma. J. Am. Acad. Dermatol. 2006 May; 54(5 Suppl): S202-5. PMID: 16631940, PII: S0190-9622(05)03004-5, DOI: 10.1016/j.jaad.2005.09.013, ISSN: 1097-6787.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/16631940.
  • Salmon JS, Thompson MA, Arildsen RC, Greer JP. Non-Hodgkin's lymphoma involving the liver: clinical and therapeutic considerations. Clin Lymphoma Myeloma. 2006 Jan; 6(4): 273-80. PMID: 16507204, PII: S1557-9190(11)70402-4, ISSN: 1557-9190.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/16507204.
  • Greer JP. Therapy of peripheral T/NK neoplasms. Hematology Am Soc Hematol Educ Program. 2006; 331-7. PMID: 17124080, PII: 2006/1/331, DOI: 10.1182/asheducation-2006.1.331, ISSN: 1520-4391.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17124080.
  • Jagasia MH, Greer JP, Morgan DS, Mineishi S, Kassim AA, Ruffner KL, Chen H, Schuening FG. Pegfilgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplant: phase II study. Bone Marrow Transplant. 2005 Jun; 35(12): 1165-9. PMID: 15880129, PII: 1704994, DOI: 10.1038/sj.bmt.1704994, ISSN: 0268-3369.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/15880129.
  • Lavely WC, Delbeke D, Greer JP, Morgan DS, Byrne DW, Price RR, Hallahan DE. FDG PET in the follow-up management of patients with newly diagnosed Hodgkin and non-Hodgkin lymphoma after first-line chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2003 Oct 10/1/2003; 57(2): 307-15. PMID: 12957239, PII: S0360301603005996, ISSN: 0360-3016.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/12957239.
  • Brogan BL, Zic JA, Kinney MC, Hu JY, Hamilton KS, Greer JP. Large B-cell lymphoma of the leg: clinical and pathologic characteristics in a North American series. J. Am. Acad. Dermatol. 2003 Aug; 49(2): 223-8. PMID: 12894069, PII: S0190962203008892, ISSN: 0190-9622.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/12894069.
  • Arrowsmith ER, Macon WR, Kinney MC, Stein RS, Goodman SA, Morgan DS, Flexner JM, Cousar JB, Jagasia MH, McCurley TL, Greer JP. Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification. Leuk. Lymphoma. 2003 Feb; 44(2): 241-9. PMID: 12688340, DOI: 10.1080/1042819021000030054, ISSN: 1042-8194.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/12688340.
  • Delbeke D, Martin WH, Morgan DS, Kinney MC, Feurer I, Kovalsky E, Arrowsmith T, Greer JP. 2-deoxy-2-[F-18]fluoro-D-glucose imaging with positron emission tomography for initial staging of Hodgkin's disease and lymphoma. Mol Imaging Biol. 2002 Jan; 4(1): 105-14. PMID: 14538054, PII: S1095039701000589, ISSN: 1536-1632.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/14538054.
  • Stein RS, Wolff SN, Greer JP, Flexner JM, Goodman S, Jagasia M, Brandt SJ, Morgan DS, Arrowsmith E, McCurley TL. Age and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapy. Leuk. Lymphoma. 2001 Sep; 42(5): 913-22. PMID: 11697646, DOI: 10.3109/10428190109097710, ISSN: 1042-8194.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/11697646.
  • Vusirikala M, Wolff SN, Stein RS, Brandt SJ, Morgan DS, Greer JP, Schuening FG, Dummer JS, Goodman SA. Valacyclovir for the prevention of cytomegalovirus infection after allogeneic stem cell transplantation: a single institution retrospective cohort analysis. Bone Marrow Transplant. 2001 Aug; 28(3): 265-70. PMID: 11535994, DOI: 10.1038/sj.bmt.1703129, ISSN: 0268-3369.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/11535994.
  • Stein RS, Greer JP, Goodman S, Brandt SJ, Morgan D, Macon WR, McCurley TL, Wolff SN. Intensified preparative regimens and allogeneic transplantation in refractory or relapsed intermediate and high grade non-Hodgkin's lymphoma. Leuk. Lymphoma. 2001 Apr; 41(3-4): 343-52. PMID: 11378547, PII: I308J001182, DOI: 10.3109/10428190109057989, ISSN: 1042-8194.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/11378547.
  • Stein RS, Greer JP, Goodman S, Brandt SJ, Morgan DS, Macon WR, McCurley TL, Wolff SN. Is total body irradiation a necessary component of preparative therapy for autologous transplantation in non-Hodgkin's lymphoma. Leuk. Lymphoma. 2001 Mar; 41(1-2): 97-103. PMID: 11342361, PII: I308J001145, DOI: 10.3109/10428190109057958, ISSN: 1042-8194.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/11342361.
  • Stein RS, Greer JP, Goodman S, Brandt SJ, Morgan DS, Macon WR, McCurley TL, Wolff SN. Limited efficacy of intensified preparative regimens and autologous transplantation as salvage therapy in high grade non-Hodgkin's lymphoma. Leuk. Lymphoma. 2001 Feb; 40(5-6): 521-8. PMID: 11426525, DOI: 10.3109/10428190109097651, ISSN: 1042-8194.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/11426525.
  • Wolff SN, Herzig R, Lynch J, Ericson SG, Greer JP, Stein R, Goodman S, Benyunes MC, Ashby M, Jones DV, Fay J. Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study. Bone Marrow Transplant. 2001 Feb; 27(3): 261-8. PMID: 11277173, DOI: 10.1038/sj.bmt.1702772, ISSN: 0268-3369.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/11277173.
  • Delbeke D, Martin WH, Morgan DS, Kinney JC, Feurer I, Kovalsky E, Arrowsmith T, Greer JP. 18F-Flourodeoxyglucose imaging with positron emission tomography for initial staging of Hodgkins disease and lymphoma. Clin Positron Imaging. 2001; ((3)): 10.
  • Dorr R, Karanes C, Spier C, Grogan T, Greer J, Moore J, Weinberger B, Schiller G, Pearce T, Litchman M, Dalton W, Roe D, List AF. Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemia. J Clin Oncol. 2001; ((19)): 1589-99.
  • Pavletic ZS, Arrowsmith ER, Bierman PJ, Goodman SA, Vose JM, Tarantolo SR, Stein RS, Bociek G, Greer JP, Wu CD, Kollath JP, Weisenburger DD, Kessinger A, Wolff SN, Armitage JO, Bishop MR. Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia. Bone Marrow Transplant. 2000 Apr; 25(7): 717-22. PMID: 10745256, DOI: 10.1038/sj.bmt.1702237, ISSN: 0268-3369.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/10745256.
  • Stein RS, Greer JP, Goodman S, Brandt SJ, Morgan DS, Macon WR, McCurley TL, Wolff SN. Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate grade non-Hodgkin's lymphoma. Bone Marrow Transplant. 2000 Feb; 25(3): 257-62. PMID: 10673696, DOI: 10.1038/sj.bmt.1702132, ISSN: 0268-3369.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/10673696.
  • Stein RS, Greer JP, Goodman S, Kallianpur A, Ahmed MS, Wolff SN. High-dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell origin. Bone Marrow Transplant. 1999 Feb; 23(3): 227-33. PMID: 10084253, DOI: 10.1038/sj.bmt.1701556, ISSN: 0268-3369.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/10084253.
  • Hodges KB, Collins RD, Greer JP, Kadin ME, Kinney MC. Transformation of the small cell variant Ki-1+ lymphoma to anaplastic large cell lymphoma: pathologic and clinical features. Am. J. Surg. Pathol. 1999 Jan; 23(1): 49-58. PMID: 9888703, ISSN: 0147-5185.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/9888703.
  • Stein RS, Greer JP, Goodman S, Kallianpur A, Ahmed MS, Wolff SN. High -dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell origin. Bone Marrow Transplant. 1999; 23227-233.
  • Kravtsov VD, Greer JP, Whitlock JA, Koury MJ. Use of the microculture kinetic assay of apoptosis to determine chemosensitivities of leukemias. Blood. 1998 Aug 8/1/1998; 92(3): 968-80. PMID: 9680366, ISSN: 0006-4971.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/9680366.
  • Larson RS, Sukpanichnant S, Greer JP, Cousar JB, Collins RD. The spectrum of multiple myeloma: diagnostic and biological implications. Hum. Pathol. 1997 Dec; 28(12): 1336-47. PMID: 9416688, ISSN: 0046-8177.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/9416688.
  • Whitlock JA, Wells RJ, Hord JD, Janco RL, Greer JP, Gay JC, Edwards JR, McCurley TL, Lukens JN. High-dose cytosine arabinoside and etoposide: an effective regimen without anthracyclines for refractory childhood acute non-lymphocytic leukemia. Leukemia. 1997 Feb; 11(2): 185-9. PMID: 9009078, ISSN: 0887-6924.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/9009078.
  • Shahab I, Greer JP, Beeker TA, Wolff SN, Collins RD, Cousar JB. Recurrent Hodgkin's disease after bone marrow transplantation. Am. J. Clin. Pathol. 1997 Jan; 107(1): 74-80. PMID: 8980371, ISSN: 0002-9173.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/8980371.
  • Zic JA, Stricklin GP, Greer JP, Kinney MC, Shyr Y, Wilson DC, King LE. Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy. J. Am. Acad. Dermatol. 1996 Dec; 35(6): 935-45. PMID: 8959953, PII: S0190-9622(96)90118-8, ISSN: 0190-9622.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/8959953.
  • Chouciño C, Goodman SA, Greer JP, Stein RS, Wolff SN, Dummer JS. Nocardial infections in bone marrow transplant recipients. Clin. Infect. Dis. 1996 Nov; 23(5): 1012-9. PMID: 8922795, ISSN: 1058-4838.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/8922795.
  • Stein RS, Greer JP, Flexner JM, Goodman S, Wolff SN. Etoposide and mitoxantrone as a second cycle of consolidation therapy following high dose cytosine arabinoside and daunorubicin in patients with acute non-lymphocytic leukemia in remission: a pilot study. Leuk. Lymphoma. 1996 Sep; 23(1-2): 93-8. PMID: 9021690, DOI: 10.3109/10428199609054806, ISSN: 1042-8194.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/9021690.
  • Hammer RD, Glick AD, Greer JP, Collins RD, Cousar JB. Splenic marginal zone lymphoma. A distinct B-cell neoplasm. Am. J. Surg. Pathol. 1996 May; 20(5): 613-26. PMID: 8619426, ISSN: 0147-5185.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/8619426.
  • List AF, Spier CS, Grogan TM, Johnson C, Roe DJ, Greer JP, Wolff SN, Broxterman HJ, Scheffer GL, Scheper RJ, Dalton WS. Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. Blood. 1996 Mar 3/15/1996; 87(6): 2464-9. PMID: 8630412, ISSN: 0006-4971.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/8630412.
  • Macon WR, Williams ME, Greer JP, Hammer RD, Glick AD, Collins RD, Cousar JB. Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes. Blood. 1996 Feb 2/15/1996; 87(4): 1474-83. PMID: 8608238, ISSN: 0006-4971.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/8608238.
  • Macon WR, Williams ME, Greer JP, Hammer RD, Glick AD, Collins RD, Cousar JB. Natrual killer-like T-cell lymphomas: Aggressive CD56+ peripheral T-cell lymphomas of large granular lymphocytes, possibly arising from thymic-independent T-cells. Blood. 1996; 871474-1483.
  • Macon WR, Tham KT, Greer JP, Wolff SN. Ringed sideroblasts: a frequent observation after bone marrow transplantation. Mod. Pathol. 1995 Sep; 8(7): 782-5. PMID: 8539238, ISSN: 0893-3952.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/8539238.
  • Greer JP, Macon WR, Lamar RE, Wolff SN, Stein RS, Flexner JM, Collins RD, Cousar JB. T-cell-rich B-cell lymphomas: diagnosis and response to therapy of 44 patients. J. Clin. Oncol. 1995 Jul; 13(7): 1742-50. PMID: 7602364, ISSN: 0732-183X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/7602364.
  • Hord JD, Gay JC, Whitlock JA, Janco RL, Edwards JR, Greer JP, Lukens JN. Long-term granulocyte-macrophage colony-stimulating factor and immunosuppression in the treatment of acquired severe aplastic anemia. J. Pediatr. Hematol. Oncol. 1995 May; 17(2): 140-4. PMID: 7749763, ISSN: 1077-4114.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/7749763.
  • Leelasiri A, Greer JP, Stein RS, Goodman S, Brandt SA, Edwards JR, Wolff SN. Graft-versus-host-disease prophylaxis for matched unrelated donor bone marrow transplantation: comparison between cyclosporine-methotrexate and cyclosporine-methotrexate-methylprednisolone. Bone Marrow Transplant. 1995 Mar; 15(3): 401-5. PMID: 7599565, ISSN: 0268-3369.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/7599565.
  • Macon WR, Williams ME, Greer JP, Cousar JB. Paracortical nodular T-cell lymphoma. Identification of an unusual variant of peripheral T-cell lymphoma. Am. J. Surg. Pathol. 1995 Mar; 19(3): 297-303. PMID: 7872427, ISSN: 0147-5185.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/7872427.
  • Stein RS, Means RT, Krantz SB, Flexner JM, Greer JP. Treatment of aplastic anemia with an investigational antilymphocyte serum prepared in rabbits. Am. J. Med. Sci. 1994 Dec; 308(6): 338-43. PMID: 7985721, PII: S0002-9629(15)35169-7, ISSN: 0002-9629.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/7985721.
  • Young WA, Greco FA, Greer JP, Hainsworth JD. Aggressive non-Hodgkin's lymphoma in the elderly: an effective, well-tolerated treatment regimen containing extended-schedule etoposide. J. Natl. Cancer Inst. 1994 Sep 9/7/1994; 86(17): 1346-7. PMID: 8064894, ISSN: 0027-8874.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/8064894.
  • Sukpanichnant S, Cousar JB, Leelasiri A, Graber SE, Greer JP, Collins RD. Diagnostic criteria and histologic grading in multiple myeloma: histologic and immunohistologic analysis of 176 cases with clinical correlation. Hum. Pathol. 1994 Mar; 25(3): 308-18. PMID: 8150462, ISSN: 0046-8177.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/8150462.
  • Kinney MC, Collins RD, Greer JP, Whitlock JA, Sioutos N, Kadin ME. A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma. Am. J. Surg. Pathol. 1993 Sep; 17(9): 859-68. PMID: 8394652, ISSN: 0147-5185.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/8394652.
  • Waits TM, Greco FA, Greer JP, Hainsworth JD. Treatment of poor prognosis non-Hodgkin's lymphoma with intensive, inpatient combination chemotherapy of brief duration: long-term followup. Leuk. Lymphoma. 1993 Aug; 10(6): 453-9. PMID: 7691308, DOI: 10.3109/10428199309148202, ISSN: 1042-8194.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/7691308.
  • Wolff SN, Fay JW, Herzig RH, Greer JP, Dummer S, Brown RA, Collins RH, Stevens DA, Herzig GP. High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant Group. Ann. Intern. Med. 1993 Jun 6/15/1993; 118(12): 937-42. PMID: 8489107, ISSN: 0003-4819.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/8489107.
  • Waits TM, Greco FA, Greer JP, Johnson DH, Wolff SN, Stein RS, McMaster ML, Hainsworth JD. Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapy. J. Clin. Oncol. 1993 May; 11(5): 943-9. PMID: 7683712, ISSN: 0732-183X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/7683712.
  • List AF, Spier C, Greer J, Wolff S, Hutter J, Door R, Salmon S, Futscher B, Baer M, Dalton W. Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia. J Clinc Oncol. 1993; ((11)): 1652-60.
  • Macon WR, Williams ME, Greer JP, Stein RS, Collins RD, Cousar JB. T-cell-rich B-cell lymphomas. A clinicopathologic study of 19 cases. Am. J. Surg. Pathol. 1992 Apr; 16(4): 351-63. PMID: 1373580, ISSN: 0147-5185.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/1373580.
  • Whitlock JA, Greer JP, Lukens JN. Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia. Cancer. 1991 Aug 8/1/1991; 68(3): 600-4. PMID: 1648435, ISSN: 0008-543X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/1648435.
  • McMaster ML, Greer JP, Wolff SN, Johnson DH, Greco FA, Stein RS, Cousar JB, Flexner JM, Hainsworth JD. Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphoma. Cancer. 1991 Jul 7/15/1991; 68(2): 233-41. PMID: 1712662, ISSN: 0008-543X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/1712662.
  • McMaster ML, Greer JP, Greco FA, Johnson DH, Wolff SN, Hainsworth JD. Effective treatment of small-noncleaved-cell lymphoma with high-intensity, brief-duration chemotherapy. J. Clin. Oncol. 1991 Jun; 9(6): 941-6. PMID: 1709685, DOI: 10.1200/JCO.1991.9.6.941, ISSN: 0732-183X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/1709685.
  • Greer JP, Kinney MC, Collins RD, Salhany KE, Wolff SN, Hainsworth JD, Flexner JM, Stein RS. Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J. Clin. Oncol. 1991 Apr; 9(4): 539-47. PMID: 1648596, ISSN: 0732-183X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/1648596.
  • McMaster ML, Johnson DH, Greer JP, Wolff SN, Hildreth CR, Greco FA, Hainsworth JD. A brief-duration combination chemotherapy for elderly patients with poor-prognosis non-Hodgkin's lymphoma. Cancer. 1991 Mar 3/15/1991; 67(6): 1487-92. PMID: 1705861, ISSN: 0008-543X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/1705861.
  • Salhany KE, Collins RD, Greer JP, Kinney MC. Long-term survival in Ki-1 lymphoma. Cancer. 1991 Jan 1/15/1991; 67(2): 516-22. PMID: 1985743, ISSN: 0008-543X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/1985743.
  • Reece DE, Barnett MJ, Conners JM, Fairey RN, Greer JP, Herzig GP, Herzig RH, Klingerman HC, OReilly SE, Shepherd JD, Spinelli JJ, Voss NJ, Wolff SN, Phillips GP. Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkins disease. J Clinc Oncol. 1991; ((9)): 1871-9.
  • List AF, Greer JP, Cousar JP, Johnson DH, Greco FA, Volsky DJ, Purtilo DT. Primary brain lymphoma in the immunocompetent host: relation to Epstein-Barr virus. Mod. Pathol. 1990 Sep; 3(5): 609-12. PMID: 2172960, ISSN: 0893-3952.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/2172960.
  • Stein RS, Greer JP, Flexner JM, Hainsworth JD, Collins RD, Macon WR, Cousar JB. Large-cell lymphomas: clinical and prognostic features. J. Clin. Oncol. 1990 Aug; 8(8): 1370-9. PMID: 2199623, ISSN: 0732-183X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/2199623.
  • Greer JP, Salhany KE, Cousar JB, Fields JP, King LE, Graber SE, Flexner JM, Stein RS, Collins RD. Clinical features associated with transformation of cerebriform T-cell lymphoma to a large cell process. Hematol Oncol. 1990 Jul; 8(4): 215-27. PMID: 2210690, ISSN: 0278-0232.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/2210690.
  • Casey TT, Cousar JB, Mangum M, Williams ME, Lee JT, Greer JP, Collins RD. Monomorphic lymphomas arising in patients with Hodgkin's disease. Correlation of morphologic, immunophenotypic, and molecular genetic findings in 12 cases. Am. J. Pathol. 1990 Jan; 136(1): 81-94. PMID: 2297052, PMCID: PMC1877457, ISSN: 0002-9440.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/2297052.
  • Salhany KE, Greer JP, Cousar JB, Collins RD. Marrow involvement in cutaneous T-cell lymphoma. A clinicopathologic study of 60 cases. Am. J. Clin. Pathol. 1989 Dec; 92(6): 747-54. PMID: 2531542, ISSN: 0002-9173.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/2531542.
  • Stein RS, Greer JP, Cousar JB, Hendey GW, Wehner JH, Flexner JM, Collins RD. Malignant lymphomas of follicular centre cell origin in man. VII. Prognostic features in small cleaved cell lymphoma. Hematol Oncol. 1989 Sep; 7(5): 381-91. PMID: 2475420, ISSN: 0278-0232.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/2475420.
  • Wolff SN, Herzig RH, Fay JW, Phillips GL, Lazarus HM, Flexner JM, Stein RS, Greer JP, Cooper B, Herzig GP. High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results. J. Clin. Oncol. 1989 Sep; 7(9): 1260-7. PMID: 2769327, ISSN: 0732-183X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/2769327.
  • Armitage JO, Greer JP, Levine AM, Weisenburger DD, Formenti SC, Bast M, Conley S, Pierson J, Linder J, Cousar JB. Peripheral T-cell lymphoma. Cancer. 1989 Jan 1/1/1989; 63(1): 158-63. PMID: 2783376, ISSN: 0008-543X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/2783376.
  • McCurley TL, Greer JP, Glick AD. Terminal deoxynucleotidyl transferase (TdT) in acute nonlymphocytic leukemia. A clinical, morphologic, cytochemical, immunologic, and ultrastructural study. Am. J. Clin. Pathol. 1988 Oct; 90(4): 421-30. PMID: 2459954, ISSN: 0002-9173.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/2459954.
  • Salhany KE, Cousar JB, Greer JP, Casey TT, Fields JP, Collins RD. Transformation of cutaneous T cell lymphoma to large cell lymphoma. A clinicopathologic and immunologic study. Am. J. Pathol. 1988 Aug; 132(2): 265-77. PMID: 3261136, PMCID: PMC1880730, ISSN: 0002-9440.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/3261136.
  • List AF, Greer JP, Cousar JC, Stein RS, Johnson DH, Reynolds VH, Greco FA, Flexner JM, Hande KR. Non-Hodgkin's lymphoma of the gastrointestinal tract: an analysis of clinical and pathologic features affecting outcome. J. Clin. Oncol. 1988 Jul; 6(7): 1125-33. PMID: 3392561, DOI: 10.1200/JCO.1988.6.7.1125, ISSN: 0732-183X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/3392561.
  • Means RT, Krantz SB, Dessypris EN, Lukens JN, Niblack GD, Greer JP, Flexner JM, Stein RS. Re-treatment of aplastic anemia with antithymocyte globulin or antilymphocyte serum. Am. J. Med. 1988 Apr; 84(4): 678-82. PMID: 3261125, PII: 0002-9343(88)90104-0, ISSN: 0002-9343.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/3261125.
  • Greer JP, Cousar JB, Miller RF, Vogler LB, Goodin JC, Graber SE, Collins RD. T4+ (helper phenotype) chronic lymphocytic leukemia: case report with liver failure and literature review. Med. Pediatr. Oncol. 1988; 16(5): 356-62. PMID: 2972899, ISSN: 0098-1532.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/2972899.
  • McCurley TL, Greer JP, Glick AD. Terminal deoxynucleotidyl transferase (TdT) in acute nonlymphocytic leukemia. A clinical, morphologic, cytochemical, immunologic and ultrastructural study. Am J Clin Pathol. 1988; ((90)): 421-30.
  • Stein RS, Magee MJ, Lenox RK, Cousar JB, Collins RD, Flexner JM, Ray W, Greer JP. Malignant lymphomas of follicular center cell origin in man. VI. Large cleaved cell lymphoma. Cancer. 1987 Dec 12/1/1987; 60(11): 2704-11. PMID: 3677005, ISSN: 0008-543X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/3677005.
  • Wolff SN, Herzig RH, Phillips GL, Lazarus HM, Greer JP, Stein RS, Ray WA, Herzig GP. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: An up date. Sem Oncol. 1987; ((2)): 12-7.
  • Greer JP, Kinney MC, Cousar JB, Flexner JM, Dupont WD, Graber SE, Greco FA, Collins RD, Stein RS. Lymphocyte-depleted Hodgkin's disease. Clinicopathologic review of 25 patients. Am. J. Med. 1986 Aug; 81(2): 208-14. PMID: 3740079, PII: 0002-9343(86)90253-6, ISSN: 0002-9343.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/3740079.
  • Greer JP, York JC, Cousar JB, Mitchell RT, Flexner JM, Collins RD, Stein RS. Peripheral T-cell lymphoma: a clinicopathologic study of 42 cases. J. Clin. Oncol. 1984 Jul; 2(7): 788-98. PMID: 6376720, ISSN: 0732-183X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/6376720.